Download PDF
Thromb Haemost 1999; 82(06): 1780-1781
DOI: 10.1055/s-0037-1614922
Letters to the Editor
Schattauer GmbH

The Methylenetetrahydrofolate Reductase Gene C677T Mutant and Ischemic Stroke in Sickle Cell Disease

M. Catherine Driscoll
1   From the Department of Hematology-Oncology, Children’s National Medical Center, Washington, DC, USA
,
Ronald Prauner
1   From the Department of Hematology-Oncology, Children’s National Medical Center, Washington, DC, USA
› Author Affiliations
Further Information

Publication History

Received 30 October 1998

Accepted after resubmission 29 June 1999

Publication Date:
10 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Noohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular Accidents in Sickle Cell Disease: Rates and Risk Factors. Blood 1998; 91: 288-94.
    PubMedGoogle Scholar
  • 2 Houston PE, Rana S, Skehsaria S, Perlin E, Kim KS, Castro OL. Homocysteine in Sickle Cell Disease: Relationship to Stroke. Amer J Med 1997; 102: 192-6.
    CrossrefPubMedGoogle Scholar
  • 3 Welch GE, Loscalzo J. Homocysteine and Atherothrombosis. NEJM 1998; 338: 1042-50.
    CrossrefPubMedGoogle Scholar
  • 4 Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395-8.
    CrossrefPubMedGoogle Scholar
  • 5 Rosenblatt DS. Inherited disorders of folate transport and metabolism. In Scriver CR, Beaudet AL, Sly WS, Valle D. (eds). The metabolic and molecular basis of inherited disease. 7th edition. New York: McGraw Hill; 1995. pp 3111-28.
    Google Scholar
  • 6 Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heurvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 1995; 10: 111-3.
    CrossrefPubMedGoogle Scholar
  • 7 Stevenson RE, Schwartz CE, Du Y, Adams MJ. Differences in methylenetetrahydrofolate reductase genotype frequencies, between whites and blacks. Am J Hum Genet 1997; 60: 229-30.
    PubMedGoogle Scholar
  • 8 Franco RF, Araujo AG, Guerreiro JF, Elion J, Zago MA. Analysis of the 677 C → T mutation of the methylenetetrahyrofolate reductase gene in different ethnic groups. Thromb Haemost 1998; 79: 119-21.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Kang S, Zhou J, Wong PWK, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43: 414-21.
    PubMedGoogle Scholar
  • 10 Guttormsen AB, Ueland PM, Nesthus I, Nygard O, Schneede J, Vollset S, Refsum H. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia. J Clin Invest 1996; 98: 2174-83.
    CrossrefPubMedGoogle Scholar
  • 11 Brattstrom L, Wilcken DEL, Ohrvik J, and Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a metaanalysis. Circulation 1998; 98: 2520-6.
    CrossrefPubMedGoogle Scholar
  • 12 Zimmerman SA, Ware RE. Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Amer J Hemat 1998; 59: 267-72.
    PubMedGoogle Scholar
  • 13 Kutlar F, Tural C, Park D, Markowitz RB, Woods KF, Kutlar A. 5,10-methylenetetrahydrofolate reductase C677T gene mutation as a candidate risk factor for avascular necrosis in patients with sickle cell disease. Blood 1998; 92: 695A.
    PubMedGoogle Scholar
  • 14 Hebbel RP, Vercellotti GM. The endothelial biology of sickle cell disease: A Review. J Lab Clin Med 1997; 288-93.
    PubMedGoogle Scholar
  • 15 Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter D, Fuchs C, Willett W, Selhub J, Hennekens C, Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57: 1098-102.
    PubMedGoogle Scholar